UNK_SMART TOUCH UNIDIRECTIONAL
Report
- Report Number
- 2029046-2022-01952
- Event Type
- Injury
- Date Received
- August 23, 2022
- Date of Event
- June 23, 2022
- Report Date
- August 22, 2022
- Manufacturer
- BIOSENSE WEBSTER INC
- Product Code
- LPB
- PMA / PMN Number
- P030031/S053
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THIS COMPLAINT IS FROM A LITERATURE SOURCE. THE FOLLOWING LITERATURE CITATION HAS BEEN REVIEWED:STEINFURT J, DALL'AGLIO PB, HUGENSCHMIDT J, STUPLICH J, JÄCKEL M, JORDAN E, LEHRMANN H, FABER TS, GRESSLER A, JADIDI AS, WESTERMANN D, ARENTZ T, TROLESE L. INITIAL CLINICAL EXPERIENCE WITH A NOVEL 8-SPLINE HIGH-RESOLUTION MAPPING CATHETER. JACC CLIN ELECTROPHYSIOL. 2022 JUN 23:S2405-500X(22)00467-4. DOI: 10.1016/J.JACEP.2022.05.010. EPUB AHEAD OF PRINT. PMID: 35780035. NO DEVICE WAS RECEIVED FOR ANALYSIS AT THE TIME OF SUBMISSION OF THE INITIAL 3500A. SINCE THE PRODUCT WAS NOT RETURNED FOR ANALYSIS, NO PRODUCT FAILURE ANALYSIS CAN BE CONDUCTED, AND NO DETERMINATION OF POSSIBLE CONTRIBUTING FACTORS COULD BE MADE. DEVICE HISTORY RECORD (DHR) REVIEW CANNOT BE CONDUCTED BECAUSE THE LOT NUMBER WAS PROVIDED BY THE CUSTOMER. THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 4. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY BIOSENSE WEBSTER INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, BIOSENSE WEBSTER INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. MANUFACTURER¿S REFERENCE NUMBER: (B)(4).
THIS COMPLAINT IS FROM A LITERATURE SOURCE. THE FOLLOWING LITERATURE CITATION HAS BEEN REVIEWED:STEINFURT J, DALL'AGLIO PB, HUGENSCHMIDT J, STUPLICH J, JÄCKEL M, JORDAN E, LEHRMANN H, FABER TS, GRESSLER A, JADIDI AS, WESTERMANN D, ARENTZ T, TROLESE L. INITIAL CLINICAL EXPERIENCE WITH A NOVEL 8-SPLINE HIGH-RESOLUTION MAPPING CATHETER. JACC CLIN ELECTROPHYSIOL. 2022 JUN 23:S2405-500X(22)00467-4. DOI: 10.1016/J.JACEP.2022.05.010. EPUB AHEAD OF PRINT. PMID: 35780035. OBJECTIVE/METHODS/STUDY DATA: : THIS STUDY SOUGHT TO REPORT THE INITIAL CLINICAL MAPPING EXPERIENCE WITH THE NOVEL 8-SPLINE OCTARAY MAPPING CATHETER IN A VARIETY OF CARDIAC ARRHYTHMIAS AND TO COMPARE THE MAPPING PERFORMANCE WITH THE 5-SPLINE PENTARAY. S FIFTY CONSECUTIVE PROCEDURES AMONG 46 PATIENTS WERE RETROSPECTIVELY ANALYZED REGARDING SAFETY, EFFICACY, AND ACUTE PROCEDURAL SUCCESS DEFINED AS TERMINATION OR NONINDUCIBILITY OF CLINICAL TACHYCARDIA, CONDUCTION BLOCK ACROSS AN ABLATION LINE, OR PULMONARY VEIN ISOLATION. IN ADDITION, ANOTHER 10 PATIENTS WITH SUSTAINED ATRIAL TACHYCARDIA MAPPED WITH THE 5-SPLINE CATHETER (2-5-2 SPACING) OR THE NOVEL 8-SPLINE CATHETER (2-2-2-2-2 SPACING) WERE ANALYZED. LOT, MODEL AND CATALOG NUMBER ARE NOT AVAILABLE, BUT THE SUSPECTED BIOSENSE DEVICE POSSIBLY ASSOCIATED WITH REPORTED ADVERSE EVENTS: THERMOCOOL SMARTTOUCH OR SMARTTOUCH SF. OTHER BIOSENSE WEBSTER DEVICES THAT WERE ALSO USED IN THIS STUDY: STEERABLE SHEATH 8.5F VIZIGO, 5-SPLINE PENTARAY MAPPING CATHETER, NOVEL 8-SPLINE OCTARAY MAPPING CATHETER NON-BIOSENSE WEBSTER DEVICES THAT WERE ALSO USED IN THIS STUDY: STEERABLE SHEATH 8.5F AGILIS NXT (ABBOTT). ADVERSE EVENT(S) AND PROVIDED INTERVENTIONS (ASSOCIATED WITH ABLATION CATHETER): QTY 1 PERICARDIAL EFFUSION (NOT RELATED TO MAPPING) - NO FURTHER INFORMATION PROVIDED. ADVERSE EVENT(S) AND PROVIDED INTERVENTIONS (INSUFFICIENT INFORMATION TO ASSOCIATE WITH SPECIFIC MANUFACTURER'S DEVICE): QTY 2 ARTERIOVENOUS FISTULAS/HEMATOMAS - NO FURTHER INFORMATION PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2388620 | UNK_SMART TOUCH UNIDIRECTIONAL | CARDIAC ABLATION PERCUTANEOUS CATHETER | LPB | BIOSENSE WEBSTER INC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Life Threatening |